98. Guidelines Series: GINA Guidelines – Biologics for Treatment of Asthma
Today, we continue our review of the Global Initiative for Asthma (GINA) guidelines on asthma. We’ve covered asthma diagnosis and phenotyping, and the initial approach to therapy. On today’s episode we’re talking about biologic therapies for asthma and will cover … Continue reading →
--------
26:34
97. Rapid Fire Journal Club – MIST 2
In this episode, we add another article to our Rapid Fire Journal Club. Luke Hedrick and Dave Furfaro discuss the MIST 2 trial published in NEJM in 2011 evaluating enzymatic therapy for complex parapneumonic effusions and empyemas. Article and … Continue reading →
--------
15:48
96. Guidelines Series: GINA Guidelines – Asthma Treatment and Management
We’re back with our second episode in our guideline initiative, and continuing our review of the Global Initiative for Asthma (GINA) guidelines on asthma. In our first episode of this series, we talked about making the diagnosis of asthma, the … Continue reading →
--------
38:09
95. Clinical Pearl: Prone Positioning with Elevated Intracranial Pressure
Today we have a mini-episode / clinical pearl. We previously discussed the PROSEVA trial and the evidence for prone positioning in ARDS. In that trial, patients with elevated intracranial pressure (ICP) were excluded. We are joined now by Dr. Jon … Continue reading →
--------
17:00
94. The Impact of Reduced NIH Indirect Cost Payments
On February 7, 2025 it was announced that the National Institutes of Health (NIH) would be capping indirect cost payments for research grants at 15%. This is a massive reduction from the current standard, and will have widespread impacts on … Continue reading →
Colombia